Works matching IS 00411132 AND DT 2024 AND VI 64 AND IP 2
Results: 30
Compound heterozygosity induces a rare Gerbich‐negative phenotype in an immunized blood donor.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 406, doi. 10.1111/trf.17711
- By:
- Publication type:
- Article
In Response: Getting the measure of hepatitis A virus (HAV): A better understanding of the RNA content of HAV reference material and blood donations.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 416, doi. 10.1111/trf.17713
- By:
- Publication type:
- Article
Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n‐of‐1 trial of weekly‐interval red cell transfusion in myelodysplastic syndromes.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 236, doi. 10.1111/trf.17706
- By:
- Publication type:
- Article
The use of mixed reality technology within the donor collection experience.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 315, doi. 10.1111/trf.17712
- By:
- Publication type:
- Article
Re‐scanning the transfusion‐transmitted disease horizon.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 195, doi. 10.1111/trf.17742
- By:
- Publication type:
- Article
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 223, doi. 10.1111/trf.17721
- By:
- Publication type:
- Article
Massive transfusion protocol reactivation as a novel marker of physician team under‐triage after injury.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 248, doi. 10.1111/trf.17719
- By:
- Publication type:
- Article
A monthly roundup of key articles in other journals.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 196, doi. 10.1111/trf.17717
- By:
- Publication type:
- Article
Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non‐relapse mortality in acute myeloid leukemia patients.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 255, doi. 10.1111/trf.17714
- By:
- Publication type:
- Article
RHD‐negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 281, doi. 10.1111/trf.17691
- By:
- Publication type:
- Article
Syphilis seroprevalence and incidence in US blood donors from 2020 to 2022.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 325, doi. 10.1111/trf.17707
- By:
- Publication type:
- Article
Identification of two novel c.11_15dup; c.17G>A variations in the ABO*B.01 allele giving rise to a weak B phenotype.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. E6, doi. 10.1111/trf.17708
- By:
- Publication type:
- Article
Continuing Medical Education.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 334, doi. 10.1111/trf.17710
- Publication type:
- Article
Characteristics of blood banking/transfusion medicine fellows in the United States, 2013–2021: Lessons learned from the Transfusion Medicine In‐Service Examination (TMISE) practice survey.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 414, doi. 10.1111/trf.17705
- By:
- Publication type:
- Article
Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 367, doi. 10.1111/trf.17704
- By:
- Publication type:
- Article
Healthcare center‐based cell therapy laboratories supporting off‐site manufactured cell therapies: The experiences of a single academic cell therapy laboratory.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 357, doi. 10.1111/trf.17703
- By:
- Publication type:
- Article
Safety of COVID‐19 convalescent plasma: A definitive systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 388, doi. 10.1111/trf.17701
- By:
- Publication type:
- Article
Hematopoietic progenitor cell count as a potential quantitative marker in apheresis products during allogeneic stem cell transplantation.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 348, doi. 10.1111/trf.17699
- By:
- Publication type:
- Article
D−− phenotype caused by a novel RHCE null allele.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. E3, doi. 10.1111/trf.17698
- By:
- Publication type:
- Article
The study of variant s antigen expression revealing a novel c.160C>T (p.Arg54Cys) variant on GYPB*s allele associated with partial s phenotype.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 380, doi. 10.1111/trf.17697
- By:
- Publication type:
- Article
Universal nucleic acid donor screening revealed epidemiological features of hepatitis E and prevented transfusion‐transmitted infection in Japan.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 335, doi. 10.1111/trf.17696
- By:
- Publication type:
- Article
Reevaluation of the medical necessity of washed red blood cell transfusion in chronically transfused adults.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 216, doi. 10.1111/trf.17690
- By:
- Publication type:
- Article
How do we use the National Healthcare Safety Network for Hemovigilance in Massachusetts?
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 200, doi. 10.1111/trf.17689
- By:
- Publication type:
- Article
The incidence of transfusion‐related acute lung injury using active surveillance: A systematic review and meta‐analysis.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 289, doi. 10.1111/trf.17688
- By:
- Publication type:
- Article
Effective peripheral blood stem cell collection in a 4.6‐kg child.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 400, doi. 10.1111/trf.17687
- By:
- Publication type:
- Article
Biochemical characterization of Jr(a−) blood type‐related ABCG2 variants: Arg147Trp and Ser572Arg disrupt the plasma membrane localization of ABCG2.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 412, doi. 10.1111/trf.17625
- By:
- Publication type:
- Article
The fatigue after infusion or transfusion pilot trial and feasibility study: A three‐armed randomized pilot trial of intravenous iron and blood transfusion for the treatment of postpartum anemia.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 301, doi. 10.1111/trf.17621
- By:
- Publication type:
- Article
Differentiating patient characteristics between platelet refractory patients with and without antibodies to human leukocyte antigens.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 210, doi. 10.1111/trf.17609
- By:
- Publication type:
- Article
Masthead and Table of Contents.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 1, doi. 10.1111/trf.17424
- Publication type:
- Article
Cover.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. C1, doi. 10.1111/trf.17423
- Publication type:
- Article